Neurobiology, Neurodegeneration and Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, United States This important study employed multiple orthogonal techniques and ...

Incumbents Jacqueline A. McAlister and Christopher M. Halliday are running with Charles V. Roche III unopposed for three seats on the city’s Board of Education. Incumbent Margaret Day ...

Roche’s com­pe­ti­tion in the eye dis­ease space is in­ten­si­fy­ing with Re­gen­eron’s high-dose Eylea and a loom­ing biosim­i­lar chal­lenge, but the Swiss phar­ma said its ...

Swiss pharma giant Roche Holding AG RHHBY posted strong growth in the third quarter. Sales increased 6% year over year to CHF 15.1 billion and were up 9% at constant exchange rates (CER).

Credit: Prostock-studio / Shutterstock. Swiss pharmaceutical company Roche has released positive topline one-year findings from a Phase IV trial of Vabysmo (faricimab) to treat diabetic macular oedema ...

Swiss pharma giant Roche (ROG: SIX) on Friday released positive top-line one-year results from the open-label, single-arm phase IV ELEVATUM study evaluating Vabysmo (faricimab) for the treatment of ...

“We established ELEVATUM to specifically evaluate Vabysmo in underrepresented populations,” said Nilesh Mehta, Roche’s Global Therapeutic Area Head for Ophthalmology. “Including diverse populations ...

1 efficacy and safety from this phase IV study were consistent with data from the Vabysmo phase III DME studies. Roche announced positive topline one-year results from the open-label, single-arm phase ...

0.1 mg/mL bovine serum albumin (BSA). Samples were loaded on a 4% acrylamide gel (acrylamide:bisacrylamide 29:1, 0.3× TBE) and migrated in 0.3× TBE for 30–70 min at 200 V. The gel was visualized using ...